Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vaccines

Free Subscription Articles published in Lancet Retrieve available abstracts of 57 articles: HTML format Text format

Single Articles

January 2019
1. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
   Cervical cancer.
   Lancet. 2019;393:169-182.
   PubMed     Text format     Abstract available
   
   
   
2. THE LANCET
   Cervical cancer: unequal progress.
   Lancet. 2019;393:104.
   PubMed     Text format    
   
   
   November 2018
3. LARSON HJ
   The state of vaccine confidence.
   Lancet. 2018;392:2244-2246.
   PubMed     Text format    
   
   
   
4. THE LANCET
   Looking beyond the Decade of Vaccines.
   Lancet. 2018;392:2139.
   PubMed     Text format    
   
   
   
5. CHANDLER J
   Fighting a polio outbreak in Papua New Guinea.
   Lancet. 2018;392:2155-2156.
   PubMed     Text format    
   
   
   
6. POWERS AM
   Licensed chikungunya virus vaccine: a possibility?
   Lancet. 2018 Nov 5. pii: S0140-6736(18)32809.
   PubMed     Text format    
   
   
   
7. REISINGER EC, Tschismarov R, Beubler E, Wiedermann U, et al
   Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial.
   Lancet. 2018 Nov 5. pii: S0140-6736(18)32488.
   PubMed     Text format     Abstract available
   
   
   October 2018
8. CLAUDE KM, Underschultz J, Hawkes MT
   Ebola virus epidemic in war-torn eastern DR Congo.
   Lancet. 2018;392:1399-1401.
   PubMed     Text format    
   
   
   
9. MARKS F, Kim JH, Rakotozandrindrainy R
   Madagascar should introduce typhoid conjugate vaccines now.
   Lancet. 2018;392:1309-1310.
   PubMed     Text format    
   
   
   September 2018
10. ZIMMER BL, Gamble L, Mayer D, Foster R, et al
    Canine rabies vaccination reduces child rabies cases in Malawi.
    Lancet. 2018;392:1115-1116.
    PubMed     Text format    
    
    
    
11. PRUE G, Baker P, Graham D, Nutting C, et al
    It is time for universal HPV vaccination.
    Lancet. 2018;392:913-914.
    PubMed     Text format    
    
    
    
12. BURKI T
    Cochrane review methods called into question.
    Lancet. 2018;392:906.
    PubMed     Text format    
    
    
    
13. HOLT E
    41 000 measles cases in Europe since the beginning of 2018.
    Lancet. 2018;392:724.
    PubMed     Text format    
    
    
    August 2018
14. HAYFLICK L
    Subject of The Vaccine Race offers perspective on errors.
    Lancet. 2018;392:633-634.
    PubMed     Text format    
    
    
    
15. LEVY Y, Lane C, Piot P, Beavogui AH, et al
    Prevention of Ebola virus disease through vaccination: where we are in 2018.
    Lancet. 2018 Aug 10. pii: S0140-6736(18)31710.
    PubMed     Text format    
    
    
    
16. THE LANCET
    Vaccine scandal and confidence crisis in China.
    Lancet. 2018;392:360.
    PubMed     Text format    
    
    
    
17. GREEN A
    HPV vaccine to be offered to boys in England.
    Lancet. 2018;392:374.
    PubMed     Text format    
    
    
    
18. YUAN X
    China's vaccine production scare.
    Lancet. 2018;392:371.
    PubMed     Text format    
    
    
    
19. FRASER B
    Measles outbreak in the Americas.
    Lancet. 2018;392:373.
    PubMed     Text format    
    
    
    July 2018
20. BAROUCH DH, Tomaka FL, Wegmann F, Stieh DJ, et al
    Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Lancet. 2018;392:232-243.
    PubMed     Text format     Abstract available
    
    
    
21. PAVLAKIS GN, Felber BK
    A new step towards an HIV/AIDS vaccine.
    Lancet. 2018;392:192-194.
    PubMed     Text format    
    
    
    
22. LEWNARD JA
    Ebola virus disease: 11 323 deaths later, how far have we come?
    Lancet. 2018;392:189-190.
    PubMed     Text format    
    
    
    
23. DEVI S
    Setbacks in the fight to eradicate polio.
    Lancet. 2018;392:201-202.
    PubMed     Text format    
    
    
    
24. BANYAI K, Estes MK, Martella V, Parashar UD, et al
    Viral gastroenteritis.
    Lancet. 2018;392:175-186.
    PubMed     Text format     Abstract available
    
    
    June 2018
25. GREEN A
    DR Congo: investigational research against Ebola virus.
    Lancet. 2018;391:2308-2309.
    PubMed     Text format    
    
    
    May 2018
26. WINSTON DJ, Mullane KM, Cornely OA, Boeckh MJ, et al
    Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2018;391:2116-2127.
    PubMed     Text format     Abstract available
    
    
    
27. CORCORAN B, Clarke A, Barrett T
    Rapid response to HPV vaccination crisis in Ireland.
    Lancet. 2018;391:2103.
    PubMed     Text format    
    
    
    
28. MACARTNEY K, Gershon AA
    Shingles vaccine after auto-HSCT decreases risk.
    Lancet. 2018;391:2082-2084.
    PubMed     Text format    
    
    
    
29. KELLY JD, Mukadi P, Dhillon RS
    Beyond vaccines: improving survival rates in the DRC Ebola outbreak.
    Lancet. 2018 May 25. pii: S0140-6736(18)31212.
    PubMed     Text format    
    
    
    
30. QADRI F, Azad AK, Flora MS, Khan AI, et al
    Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh.
    Lancet. 2018;391:1877-1879.
    PubMed     Text format    
    
    
    
31. AGUIAR M
    Dengue vaccination: a more ethical approach is needed.
    Lancet. 2018;391:1769-1770.
    PubMed     Text format    
    
    
    
32. HARGREAVES S, Nellums LB, Ramsay M, Saliba V, et al
    Who is responsible for the vaccination of migrants in Europe?
    Lancet. 2018;391:1752-1754.
    PubMed     Text format    
    
    
    April 2018
33. THE LANCET
    Addressing decreasing vaccine coverage in the EU.
    Lancet. 2018;391:1638.
    PubMed     Text format    
    
    
    
34. CHEN S, Li J, Wang D, Fung H, et al
    The hepatitis B epidemic in China should receive more attention.
    Lancet. 2018;391:1572.
    PubMed     Text format    
    
    
    March 2018
35. PENG X, Hu X, Salazar MA
    On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine.
    Lancet. 2018 Mar 28. pii: S0140-6736(18)30483.
    PubMed     Text format    
    
    
    
36. WATTS G
    New York Challenge sets high bar for HPV vaccination.
    Lancet. 2018;391:1137.
    PubMed     Text format    
    
    
    
37. METZGER WG, Vivas-Martinez S
    Questionable efficacy of the rVSV-ZEBOV Ebola vaccine.
    Lancet. 2018;391:1021.
    PubMed     Text format    
    
    
    
38. LONGINI IM, Rottingen JA, Kieny MP, Edmunds WJ, et al
    Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply.
    Lancet. 2018;391:1021-1022.
    PubMed     Text format    
    
    
    February 2018
39. PANG T, Gubler D, Goh DYT, Ismail Z, et al
    Dengue vaccination: a more balanced approach is needed.
    Lancet. 2018;391:654.
    PubMed     Text format    
    
    
    
40. LARSON HJ
    A global girl gang.
    Lancet. 2018;391:527-528.
    PubMed     Text format    
    
    
    
41. PAULES CI, Subbarao K
    Influenza vaccination and prevention of cardiovascular disease mortality - Authors' reply.
    Lancet. 2018;391:427-428.
    PubMed     Text format    
    
    
    
42. CALDEIRA D, Ferreira JJ, Costa J
    Influenza vaccination and prevention of cardiovascular disease mortality.
    Lancet. 2018;391:426-427.
    PubMed     Text format    
    
    
    
43. THE LANCET
    Yellow fever: a major threat to public health.
    Lancet. 2018;391:402.
    PubMed     Text format    
    
    
    January 2018
44. THE LANCET
    Preparing for seasonal influenza.
    Lancet. 2018;391:180.
    PubMed     Text format    
    
    
    
45. THE LANCET
    A new vaccine for typhoid control.
    Lancet. 2018;391:96.
    PubMed     Text format    
    
    
    
46. PETOUSIS-HARRIS H, Paynter J, Morgan J, Saxton P, et al
    Pitfalls of the healthy vaccinee effect - Authors' reply.
    Lancet. 2018;391:123-124.
    PubMed     Text format    
    
    
    
47. MAHMUD SM, Righolt CH
    Pitfalls of the healthy vaccinee effect.
    Lancet. 2018;391:123.
    PubMed     Text format    
    
    
    
48. ZAFFRAN M, McGovern M, Hossaini R, Martin R, et al
    The polio endgame: securing a world free of all polioviruses.
    Lancet. 2018;391:11-13.
    PubMed     Text format    
    
    
    December 2017
49. MARQUES ETA, Burke DS
    Tradition and innovation in development of a Zika vaccine.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33107.
    PubMed     Text format    
    
    
    
50. GAUDINSKI MR, Houser KV, Morabito KM, Hu Z, et al
    Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33105.
    PubMed     Text format     Abstract available
    
    
    
51. MODJARRAD K, Lin L, George SL, Stephenson KE, et al
    Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33106.
    PubMed     Text format     Abstract available
    
    
    October 2017
52. YIN Y
    HPV vaccination in China needs to be more cost-effective.
    Lancet. 2017;390:1735-1736.
    PubMed     Text format    
    
    
    September 2017
53. JIN C, Gibani MM, Moore M, Juel HB, et al
    Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.
    Lancet. 2017 Sep 28. pii: S0140-6736(17)32149.
    PubMed     Text format     Abstract available
    
    
    
54. FEASEY NA, Levine MM
    Typhoid vaccine development with a human challenge model.
    Lancet. 2017 Sep 28. pii: S0140-6736(17)32407.
    PubMed     Text format    
    
    
    
55. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
    Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
    PubMed     Text format     Abstract available
    
    
    
56. DENNY L
    Nine-valent human papillomavirus vaccine: great science, but will it save lives?
    Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
    PubMed     Text format    
    
    
    November 2016
57. DENNY L, de Sanjose S, Mutebi M, Anderson BO, et al
    Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries.
    Lancet. 2016 Nov 1. pii: S0140-6736(16)31795.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: